Submission Details
| 510(k) Number | K091960 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 01, 2009 |
| Decision Date | August 29, 2011 |
| Days to Decision | 789 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K091960 is an FDA 510(k) clearance for the VYSIS EGR1 FISH PROBE KIT (VYSIS LSI EGR1 SPECTRUM/ORANGE/D5S23, D5S721, SPECTRUM GREEN PROBE), MODEL 4N37-020, a Early Growth Response 1 (egr) Fish Probe Kit (Class II — Special Controls, product code OWK), submitted by Abbott Molecular, Inc. (Des Plaines, US). The FDA issued a Cleared decision on August 29, 2011, 789 days after receiving the submission on July 1, 2009. This device falls under the Pathology review panel. Regulated under 21 CFR 866.6040.
| 510(k) Number | K091960 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 01, 2009 |
| Decision Date | August 29, 2011 |
| Days to Decision | 789 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | OWK — Early Growth Response 1 (egr) Fish Probe Kit |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.6040 |
| Definition | The Egr1 Fish Probe Kit Is Intended To Detect Deletion Of The Lsi Egr1 Probe Target In Bone Marrow Specimens And May Be Used, In Addition To Cytogenetics, Other Biomarkers, Morphology, And Other Clinical Information, At The Time Of Diagnosis As An Aid In Determining The Prognosis Of Acute Myeloid Leukemia (aml) Patients. |